山东泰山灵芝集团战略沟通会隆重召开,提升患者整体福祉!

Core Viewpoint - The health and wellness industry is focusing on enhancing patient well-being, with Shandong Taishan Ganoderma Group actively participating in this mission through strategic initiatives and collaborations [1][3]. Group 1: Achievements in Patient Well-being - Over the past year, Shandong Taishan Ganoderma Group has made significant progress in enhancing patient well-being through increased investment in product research and development, collaborating with renowned universities and research institutions [3]. - The company’s health technology division has been recognized as a key project for green, low-carbon, and high-quality development in Shandong Province, highlighting its commitment to sustainable practices [3]. - The modern factory located at the foot of Mount Tai features a 4,000 square meter transparent, visible, and ten-thousand-level purification workshop, adhering to GMP standards to ensure product quality and safety [3]. - The factory is expected to achieve an annual production capacity of 150 tons of broken spore powder and 300 tons of ganoderma extract, significantly enhancing market supply capabilities [3]. Group 2: Future Development Plans - The chairman of Shandong Taishan Ganoderma Group outlined the 2025 work priorities, focusing on deepening research into the medicinal value of ganoderma and accelerating the development of new products targeting chronic diseases and immune enhancement [4]. - The company plans to optimize production processes by introducing intelligent management systems to improve efficiency, product quality stability, and reduce production costs, making high-quality ganoderma products more affordable for patients [4]. - The company aims to uphold the philosophy of "inheriting the thousand-year ganoderma culture and innovating the modern health industry," emphasizing technological advancement, market orientation, and patient well-being [4].